SPPL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.498200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.669000E-01
Normal-vs-Stage2
3.873800E-01
Normal-vs-Stage3
2.288600E-01
Normal-vs-Stage4
2.956400E-01
Stage1-vs-Stage2
8.598400E-01
Stage1-vs-Stage3
3.186200E-01
Stage1-vs-Stage4
7.233400E-01
Stage2-vs-Stage3
2.531000E-01
Stage2-vs-Stage4
8.445200E-01
Stage3-vs-Stage4
5.439400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.807800E-01
Normal-vs-AfricanAmerican
2.876200E-01
Normal-vs-Asian
2.451800E-01
Caucasian-vs-AfricanAmerican
6.300200E-01
Caucasian-vs-Asian
3.618400E-01
AfricanAmerican-vs-Asian
8.571200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.779800E-01
Normal-vs-Female
2.908600E-01
Male-vs-Female
1.989570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.697000E-01
Normal-vs-Age(41-60Yrs)
8.325400E-01
Normal-vs-Age(61-80Yrs)
3.110000E-01
Normal-vs-Age(81-100Yrs)
3.560600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.783200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.936000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.685400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.304100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.395590E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.899400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.535640E-01
Normal-vs-Daily Drinker
6.628400E-01
Normal-vs-Weekly Drinker
3.150800E-01
Normal-vs-Occasional Drinker
9.503600E-01
Normal-vs-Social Drinker
3.900000E-01
Non Drinker-vs-Daily Drinker
6.183600E-02
Non Drinker-vs-Weekly Drinker
5.462200E-01
Non Drinker-vs-Occasional Drinker
5.661800E-03
Non Drinker-vs-Social Drinker
1.891200E-01
Daily Drinker-vs-Weekly Drinker
3.346000E-01
Daily Drinker-vs-Occasional Drinker
3.486800E-01
Daily Drinker-vs-Social Drinker
6.353400E-01
Weekly Drinker-vs-Occasional Drinker
7.814000E-02
Weekly Drinker-vs-Social Drinker
5.733000E-01
Occasional Drinker-vs-Social Drinker
1.619550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.404840E-01
Normal-vs-Grade 2
4.586000E-01
Normal-vs-Grade 3
1.246220E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.313400E-01
Grade 1-vs-Grade 3
7.299600E-01
Grade 1-vs-Grade 4
1.404840E-01
Grade 2-vs-Grade 3
4.174600E-01
Grade 2-vs-Grade 4
4.586000E-01
Grade 3-vs-Grade 4
1.246220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.336600E-01
Normal-vs-NonDiabetic
5.365600E-01
Diabetic-vs-NonDiabetic
1.449790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.621000E-01
Normal-vs-NoPancreatitis
4.521000E-01
Pancreatitis-vs-NoPancreatitis
9.774800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.613200E-01
Normal-vs-N1
4.282000E-01
N0-vs-N1
9.875400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.339000E-01
Normal-vs-TP53-NonMutant
6.954400E-01
TP53-Mutant-vs-TP53-NonMutant
5.768800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
